Fig. 2From: Impaired antibody responses were observed in patients with type 2 diabetes mellitus after receiving the inactivated COVID-19 vaccinesThe percentage of RBD-specific MBCs and their subsets. a All participants of T2DM and HCs. b BMI in patients with T2DM. c FPG in patients with T2DM. d HbA1c in patients with T2DM. e Treatment with and without insulin in patients with T2DM. f T2DM alone and T2DM combined with other independent chronic diseasesBack to article page